Biotech Analysts discuss Elektrofi and their partnership with ARGX, in the development of Hypercon, a high-concentration protein technology to enable conversion of IV into basic s.c. injections on an Analyst/Industry conference call to be held on April 10 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX: